Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
The Journal of Pharmacology and Experimental Therapeutics|February 8, 2025
Entourage effects of nonpsychotropic cannabinoids on visceral sensitivity in experimental colitisKristofer Svendsen, Amyaouch Bradaia, Maria A Gandini, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 27, 2006
Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory functionYasmin Nasser, Ester Fernandez, Catherine M Keenan, et al.
JACC. Basic to Translational Science|September 19, 2024
Reduced Stroke Volume and Brain Perfusion Drive Postural Hyperventilation in Postural Orthostatic Tachycardia SyndromeJacquie R Baker, Anthony V Incognito, Shaun I Ranada, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 4, 2025
Microbial dysbiosis alters serotonin signaling in a postinflammatory murine model of visceral painTimothy D Roth, Lillian Russo-Savage, Yasaman Bahojb Habibyan, et al.
Pharmacology, Biochemistry, and Behavior|November 9, 2010
The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the ratNina L Cluny, Adam P Chambers, V Kiran Vemuri, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 10, 2023
Insulin-Like Growth Factor1 Preserves Gastric Pacemaker Cells and Motor Function in Aging via ERK1/2 ActivationVy Truong Thuy Nguyen, Negar Taheri, Egan L Choi, et al.
Inflammatory Bowel Diseases|May 20, 2022
Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel DiseaseBradley G Goodyear, Faranak Heidari, Richard J M Ingram, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2022
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalenceChristopher N Andrews, Renata Rehak, Matthew Woo, et al.
Pageof 24